Ray Dalio's INSM Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 295,579 shares of Insmed Incorporated (INSM) worth $48.33 M, representing 0.22% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in INSM, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Insmed Incorporated (INSM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Insmed Incorporated (INSM) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +295,579 | New Buy | 295,579 | $163.52 |
Ray Dalio's Insmed Incorporated Investment FAQs
Ray Dalio first purchased Insmed Incorporated (INSM) in Q1 2026, acquiring 295,579 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Insmed Incorporated (INSM) for 1 quarters since Q1 2026.
Ray Dalio's largest addition to Insmed Incorporated (INSM) was in Q1 2026, adding 295,579 shares worth $48.33 M.
According to the latest 13F filing for Q1 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 295,579 shares of Insmed Incorporated (INSM), valued at approximately $48.33 M.
As of the Q1 2026 filing, Insmed Incorporated (INSM) represents approximately 0.22% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Insmed Incorporated (INSM) was 295,579 shares, as reported at the end of Q1 2026.